Comparative Analysis of First-Line FOLFOX Treatment With and Without Anti-VEGF Therapy in Metastatic Colorectal Carcinoma: A Real-World Data Study.

Ronen BrennerShlomit Amar-FarkashAvital Klein-BrillKeren Rosenberg-KatzDvir Aran

Published in: Cancer control : journal of the Moffitt Cancer Center (2023)

Our real-world data analysis suggests that the addition of anti-VEGF to FOLFOX offers limited and short-lived benefits in the context of mCRC and may provide differential survival benefit based on tumor sidedness.

Keyphrases

data analysis
vascular endothelial growth factor
endothelial cells
squamous cell carcinoma
small cell lung cancer
electronic health record
big data
machine learning
free survival
artificial intelligence